Skip to content

Clinical trials

Phase 3 Hypertension trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Spain Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20054
20064
20071
20085
20093
20101
20111
20121
20132
20141
20151
20183
20193
20202
20212
20221
20233
20242
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Active, not recruiting5
Terminated4
Recruiting3
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
AstraZeneca5
Novartis5
Novartis Pharmaceuticals4
Eli Lilly and Company3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Corcept Therapeutics2
Gilead Sciences2
GlaxoSmithKline2
Mineralys Therapeutics Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension48
Cardiovascular Diseases8
Diabetes Mellitus, Type 24
Pulmonary Arterial Hypertension4
Renal Insufficiency, Chronic4
Diabetes Mellitus3
ACTH Syndrome, Ectopic2
Connective Tissue Diseases2
Cushing Syndrome2
Essential Hypertension2

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.